These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38719690)

  • 1. Hypothetical adhesin CAM87009.1 formulated in alum or biogenic silver nanoparticles protects mice from lethal infection by multidrug-resistant Acinetobacter baumannii.
    Buchhorn de Freitas S; Clair Pinto Seixas Neto A; Aparecido Panagio L; Pereira Soares M; Drawanz Hartwig D
    Vaccine; 2024 Jul; 42(18):3802-3810. PubMed ID: 38719690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypothetical adhesin protein induces anti-biofilm antibodies against multi-drug resistant Acinetobacter baumannii.
    de Freitas SB; Wozeak DR; Neto AS; Cardoso TL; Hartwig DD
    Microb Pathog; 2021 Oct; 159():105112. PubMed ID: 34314810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
    Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
    Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.
    Shu MH; MatRahim N; NorAmdan N; Pang SP; Hashim SH; Phoon WH; AbuBakar S
    Sci Rep; 2016 Feb; 6():22332. PubMed ID: 26923424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprotectivity of Valine-glycine repeat protein G, a potent mediator of pathogenicity, against Acinetobacter baumannii.
    Pazoki M; Darvish Alipour Astaneh S; Ramezanalizadeh F; Jahangiri A; Rasooli I
    Mol Immunol; 2021 Jul; 135():276-284. PubMed ID: 33940514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergic and addictive activity of biogenic silver nanoparticle associated with meropenem against carbapenem-resistant Acinetobacter baumannii.
    Allend SO; Oliveira Garcia M; da Cunha KF; de Albernaz DTF; Panagio LA; Nakazaro G; Reis GF; Oliveira TL; Neto ACPS; Hartwig DD
    J Appl Microbiol; 2024 Mar; 135(3):. PubMed ID: 38383758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strain of Acinetobacter baumannii and characterization of its ghost as a candidate vaccine.
    Sheweita SA; Batah AM; Ghazy AA; Hussein A; Amara AA
    J Infect Public Health; 2019; 12(6):831-842. PubMed ID: 31230953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.
    Samo M; Choudhary NR; Riebe KJ; Shterev I; Staats HF; Sempowski GD; Leduc I
    Vaccine; 2016 Feb; 34(9):1193-200. PubMed ID: 26812077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.
    Lin L; Tan B; Pantapalangkoor P; Ho T; Hujer AM; Taracila MA; Bonomo RA; Spellberg B
    Vaccine; 2013 Jan; 31(2):313-8. PubMed ID: 23153442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B.
    Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD
    J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
    Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
    Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.